Skip to content
Yog Pharma
CardiovascularLoop diuretic

Furosemide is a loop diuretic indicated for edema associated with heart failure, cirrhosis and renal disease, and hypertension. We supply it to US manufacturers of tablets, oral solution and injection.

CAS54-31-9330.7 g/molC12H11ClN2O5S
2D structure of Furosemide.

Data from PubChem (CID 3440) and FDA’s substance registry

CAS number

54-31-9

Molecular formula

C12H11ClN2O5S

Molecular weight

330.7g/mol

FDA UNII

IUPAC name

4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid

InChIKey

ZZUFCTLCJUWOSV-UHFFFAOYSA-N

Appearance
White to slightly yellowish, odorless crystalline powder.
Solubility
Practically insoluble in water, sparingly soluble in alcohol, freely soluble in dilute alkali solutions and insoluble in dilute acids.

Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.

Worth settling with your inquiry

Discolors on exposure to light, so light-resistant packaging matters. Injection-grade material carries tighter limits than oral grade; say which you need.

On the US market

Reference product
LasixNDA 016273
Approved ANDAs
22 with a marketed product
Approved forms and strengths
  • Tablet 20 mg, 40 mg, 80 mg
  • Injection 10 mg/mL
  • Subcutaneous injection 80 mg/10 mL, 80 mg/2.67 mL, 80 mg/mL
  • Oral solution 10 mg/mL, 40 mg/5 mL

Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. The brand name belongs to its owner and identifies the reference product only.

Grade

USP or Ph. Eur. where a monograph exists, or your own specification.

Quantities

From development quantities for formulation work to commercial supply.

Packaging

To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.

Regulatory filings

US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.

Documents available with a quote

  • Specification and certificate of analysis
  • Safety data sheet
  • Method of analysis
  • DMF letter of authorization, where a US DMF is filed
  • GMP certificate and inspection history of the site
  • Residual solvents and elemental impurities statements
  • Nitrosamine risk assessment
  • TSE/BSE statement

Need something else for your QA file? Email info@yogpharma.com